MoonLake Immunotherapeut... Stock Quote MLTX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

48.18

Bid

46.00

Ask

50.00

Volume

0.00 Day's Range 0.00

35.11 52 Week Range 64.98

Market Cap

3.078B

Previous Close

48.18

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

356,423

Shares Outstanding

63,883,904

Dividend Yield

PE Ratio

-69.90

Earnings Per Share (EPS)

-0.69

Revenue

Net Profit

-44.08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector

Blank Checks

Industry

Pharmaceutical Preparations

Website

moonlaketx.com

Headquarters

Grand Cayman, Cym

Founded

2020

MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $48.18. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 35.11 to $ 64.98.

MoonLake Immunotherapeut... currently has 63,883,904 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $3.08 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -69.90.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody® sonelokimab in...

Form 8-K - Current report

MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis Builds upon the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.93	8.8813559322	44.25	48.57	43.535	236830	46.96317022	CS
4	3.23	7.18576195773	44.95	48.57	39.36	337047	44.1192225	CS
12	7.04	17.1122994652	41.14	50.53	37.55	356423	43.30022231	CS
26	-10.91	-18.4633609748	59.09	59.735	37.55	406458	45.42798468	CS
52	-9.83	-16.9453542493	58.01	64.98	35.11	498121	49.30378863	CS
156	35.81	289.490703314	12.37	64.98	4.25	355198	42.11167827	CS
260	35.81	289.490703314	12.37	64.98	4.25	355198	42.11167827	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1231 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.38 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.47 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.60 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1231 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.38 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.47 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.60 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1231 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.38 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.47 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.60 (0.00%)	0